✦ LIBER ✦

Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects

✍ Scribed by Akizuki, S; Mizorogi, F; Inoue, T; Sudo, K; Ohnishi, A

Book ID: 110012806
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 120 KB
Volume: 26
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702641

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of intravenous recombin

Pharmacokinetics of intravenous recombinant human granulocyte colony-stimulating factor (rhG-CSF) in children receiving myelosuppressive cancer chemotherapy: Clearance increases in relation to absolute neutrophil count with repeated dosing

✍ Sturgill, Marc G.; Huhn, Richard D.; Drachtman, Richard A.; Ettinger, Alice G.; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Limited evidence suggests increased efficacy of rhG-CSF by subcutaneous (SQ) compared with intravenous (IV) administration. To examine the possibility that rapid elimination of IV rhG-CSF could substantially shorten the duration of systemic exposure and could explain a difference in pharmacodynamics

A Phase II Double-Blind Randomized Study

A Phase II Double-Blind Randomized Study of the Simultaneous Administration of Recombinant Human Interleukin-6 and Recombinant Human Granulocyte Colony-Stimulating Factor Following Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

✍ Howard Hochster; James L. Speyer; John P. Mandeli; Carolyn Runowicz; Scott Wadle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 51 KB